804 related articles for article (PubMed ID: 22488699)
1. A prospective surveillance model for physical rehabilitation of women with breast cancer: chemotherapy-induced peripheral neuropathy.
Stubblefield MD; McNeely ML; Alfano CM; Mayer DK
Cancer; 2012 Apr; 118(8 Suppl):2250-60. PubMed ID: 22488699
[TBL] [Abstract][Full Text] [Related]
2. A prospective surveillance model for rehabilitation for women with breast cancer.
Stout NL; Binkley JM; Schmitz KH; Andrews K; Hayes SC; Campbell KL; McNeely ML; Soballe PW; Berger AM; Cheville AL; Fabian C; Gerber LH; Harris SR; Johansson K; Pusic AL; Prosnitz RG; Smith RA
Cancer; 2012 Apr; 118(8 Suppl):2191-200. PubMed ID: 22488693
[TBL] [Abstract][Full Text] [Related]
3. A prospective model of care for breast cancer rehabilitation: postoperative and postreconstructive issues.
McNeely ML; Binkley JM; Pusic AL; Campbell KL; Gabram S; Soballe PW
Cancer; 2012 Apr; 118(8 Suppl):2226-36. PubMed ID: 22488697
[TBL] [Abstract][Full Text] [Related]
4. Patient perspectives on breast cancer treatment side effects and the prospective surveillance model for physical rehabilitation for women with breast cancer.
Binkley JM; Harris SR; Levangie PK; Pearl M; Guglielmino J; Kraus V; Rowden D
Cancer; 2012 Apr; 118(8 Suppl):2207-16. PubMed ID: 22488695
[TBL] [Abstract][Full Text] [Related]
5. Upper-body morbidity after breast cancer: incidence and evidence for evaluation, prevention, and management within a prospective surveillance model of care.
Hayes SC; Johansson K; Stout NL; Prosnitz R; Armer JM; Gabram S; Schmitz KH
Cancer; 2012 Apr; 118(8 Suppl):2237-49. PubMed ID: 22488698
[TBL] [Abstract][Full Text] [Related]
6. A questionnaire survey of physicians' perspectives regarding the assessment of chemotherapy-induced peripheral neuropathy in patients with breast cancer.
Kuroi K; Shimozuma K; Ohashi Y; Takeuchi A; Aranishi T; Morita S; Ohsumi S; Watanabe T; Bain S; Hausheer FH
Jpn J Clin Oncol; 2008 Nov; 38(11):748-54. PubMed ID: 18845520
[TBL] [Abstract][Full Text] [Related]
7. Background noise: the experience of chemotherapy-induced peripheral neuropathy.
Bakitas MA
Nurs Res; 2007; 56(5):323-31. PubMed ID: 17846553
[TBL] [Abstract][Full Text] [Related]
8. Sweet bee venom pharmacopuncture for chemotherapy-induced peripheral neuropathy.
Yoon J; Jeon JH; Lee YW; Cho CK; Kwon KR; Shin JE; Sagar S; Wong R; Yoo HS
J Acupunct Meridian Stud; 2012 Aug; 5(4):156-65. PubMed ID: 22898064
[TBL] [Abstract][Full Text] [Related]
9. Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: a case series.
Park JW; Jeon JH; Yoon J; Jung TY; Kwon KR; Cho CK; Lee YW; Sagar S; Wong R; Yoo HS
Integr Cancer Ther; 2012 Jun; 11(2):166-71. PubMed ID: 21715371
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy-induced peripheral neuropathy: an unresolved issue].
Velasco R; Bruna J
Neurologia; 2010 Mar; 25(2):116-31. PubMed ID: 20487712
[TBL] [Abstract][Full Text] [Related]
11. The Association of Chemotherapy-Induced Peripheral Neuropathy Symptoms and the Risk of Falling.
Kolb NA; Smith AG; Singleton JR; Beck SL; Stoddard GJ; Brown S; Mooney K
JAMA Neurol; 2016 Jul; 73(7):860-6. PubMed ID: 27183099
[TBL] [Abstract][Full Text] [Related]
12. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
[TBL] [Abstract][Full Text] [Related]
13. Stakeholder perspectives on dissemination and implementation of a prospective surveillance model of rehabilitation for breast cancer treatment.
Stout NL; Andrews K; Binkley JM; Schmitz KH; Smith RA
Cancer; 2012 Apr; 118(8 Suppl):2331-4. PubMed ID: 22488707
[TBL] [Abstract][Full Text] [Related]
14. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients.
Bao T; Seidman AD; Piulson L; Vertosick E; Chen X; Vickers AJ; Blinder VS; Zhi WI; Li Q; Vahdat LT; Dickler MN; Robson ME; Mao JJ
Eur J Cancer; 2018 Sep; 101():12-19. PubMed ID: 30007894
[TBL] [Abstract][Full Text] [Related]
15. Case report: painful peripheral neuropathy following treatment with docetaxel for breast cancer.
Wampler MA; Hamolsky D; Hamel K; Melisko M; Topp KS
Clin J Oncol Nurs; 2005 Apr; 9(2):189-93. PubMed ID: 15853162
[TBL] [Abstract][Full Text] [Related]
16. Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).
Binda D; Vanhoutte EK; Cavaletti G; Cornblath DR; Postma TJ; Frigeni B; Alberti P; Bruna J; Velasco R; Argyriou AA; Kalofonos HP; Psimaras D; Ricard D; Pace A; Galiè E; Briani C; Dalla Torre C; Lalisang RI; Boogerd W; Brandsma D; Koeppen S; Hense J; Storey D; Kerrigan S; Schenone A; Fabbri S; Rossi E; Valsecchi MG; Faber CG; Merkies IS; ; Galimberti S; Lanzani F; Mattavelli L; Piatti ML; Bidoli P; Cazzaniga M; Cortinovis D; Lucchetta M; Campagnolo M; Bakkers M; Brouwer B; Boogerd W; Grant R; Reni L; Piras B; Pessino A; Padua L; Granata G; Leandri M; Ghignotti I; Plasmati R; Pastorelli F; Heimans JJ; Eurelings M; Meijer RJ; Grisold W; Lindeck Pozza E; Mazzeo A; Toscano A; Russo M; Tomasello C; Altavilla G; Penas Prado M; Dominguez Gonzalez C; Dorsey SG
Eur J Cancer; 2013 Sep; 49(13):2910-8. PubMed ID: 23668917
[TBL] [Abstract][Full Text] [Related]
17. Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy.
Molassiotis A; Cheng HL; Lopez V; Au JSK; Chan A; Bandla A; Leung KT; Li YC; Wong KH; Suen LKP; Chan CW; Yorke J; Farrell C; Sundar R
BMC Cancer; 2019 Feb; 19(1):132. PubMed ID: 30736741
[TBL] [Abstract][Full Text] [Related]
18. Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.
Kleckner IR; Kamen C; Gewandter JS; Mohile NA; Heckler CE; Culakova E; Fung C; Janelsins MC; Asare M; Lin PJ; Reddy PS; Giguere J; Berenberg J; Kesler SR; Mustian KM
Support Care Cancer; 2018 Apr; 26(4):1019-1028. PubMed ID: 29243164
[TBL] [Abstract][Full Text] [Related]
19. Effects of Chemotherapy-Induced Peripheral Neuropathy in Women With Breast Cancer: A Structural Equation Approach With the Theory of Unpleasant Symptoms.
Kim M; Jung MS
Cancer Nurs; 2021 Mar-Apr 01; 44(2):145-153. PubMed ID: 31833921
[TBL] [Abstract][Full Text] [Related]
20. Assessing gait, balance, and muscle strength among breast cancer survivors with chemotherapy-induced peripheral neuropathy (CIPN): study protocol for a randomized controlled clinical trial.
Teran-Wodzinski P; Haladay D; Vu T; Ji M; Coury J; Adams A; Schwab L; Visovsky C
Trials; 2022 Apr; 23(1):363. PubMed ID: 35477489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
